Dividend Aristocrats are among Wall Street’s most beloved stocks.
Some companies pay dividends, fewer companies manage to grow those dividends, and still fewer companies manage to join the ranks of the Dividend Aristocrats, which are companies that have improved their payouts on an annual basis for at least 25 consecutive years.
Why is it important that a dividend get larger over time? Well, it helps to offset the purchasing power that the dollar loses to rising prices each year. In a good-case scenario, dividend growth actually helps you outrun the bite of inflation.
It’s fair to say, then, that Dividend Aristocrats have helped their shareholders fend off rising consumer prices for at least a quarter of a century.
Let’s take some time to learn about the Dividend Aristocrats, and then I’ll introduce you to the 10 best-rated stocks within the most popular subset of Aristocrats: the S&P 500 Dividend Aristocrats.
Disclaimer: This article does not constitute individualized investment advice. Securities, funds, and/or other investments appear for your consideration and not as personalized investment recommendations. Act at your own discretion.
Editor’s Note: Tabular data presented in this article are up-to-date as of Nov. 19, 2025.
Table of Contents
Why You Should Care About Dividend Growth
A dividend program, in and of itself, is a powerful statement by corporate management about their company’s ability to generate profits—specifically, it implies that they expect to produce enough in earnings on a regular basis that they can share some of it with us.
That’s great! If a company went from paying us nothing at all to paying us, say, a dollar per share every year for the rest of our lives, we wouldn’t have much room for complaint.
But a company that started paying us a dollar per share one year, then raised it every year after that, would look a lot more attractive, for several reasons:
1. A higher dividend over time means a higher “yield on cost” for us. If we bought a share of stock for $100, that $1 per share would equal a 1% yield on our purchase. If the stock price and dividend both doubled, to $200 per share and $2, respectively, new investors would still be buying at a 1% yield. But us? We’d be earning 2% on our original $100 purchase.
2. A higher dividend over time fends off inflation. In most years, we experience inflation, which is when the worth of our currency slightly declines. So $1 worth of groceries, gas, etc. this year will generally buy you slightly less groceries, gas, etc. next year. High inflation over the past few years really drives home this point—according to the U.S. Bureau of Labor Statistics, in January 2025 you would need $1.88 to buy what $1 could have bought in January 2020, right before the COVID pandemic hit a fever pitch. So if you receive $1 in dividends every year in perpetuity, your dividend income will lose its value over time. But if that initial $1 dividend is raised enough every year, your income could keep pace with (or even outrun) inflation.
3. A higher dividend can be a sign of quality. Just like initiating a dividend says “we have so much money that you can have some,” a track record of raising dividends typically signals a company’s ability to continue growing its bottom line.
Put simply: Regular dividend growth signals a higher caliber of operations (and thus potentially a higher caliber of stock), and it puts more money in our pockets. That’s a lot to love.
The S&P 500 Dividend Aristocrats
The term “Dividend Aristocrats” generally refers to stocks with some sort of track record of dividend growth. There are, in fact, many types of Dividend Aristocrats—European Aristocrats, Canadian Aristocrats, mid-cap Aristocrats, and so on—and each group has a certain set of criteria for inclusion, including a baseline of dividend growth.
But most discussions around Dividend Aristocrats revolve around one particular subset: the S&P 500 Dividend Aristocrats.
The S&P 500 Dividend Aristocrats are the biggest, blue-chip dividend growers that the U.S. equity markets have to offer. And ultimately, they have to meet just two criteria for inclusion:
1. Be members of the S&P 500.
2. Have increased dividends for at least 25 consecutive years.
That second criterion needs a little explaining, however.
There’s More Than One Way to Grow Dividends Every Year
Most companies’ annual dividend increases go exactly the way you’d expect: Every year, they raise the amount they regularly pay across the calendar.
Example: Woodley Inc. (KW) distributed $1 per share every quarter in 2024, then to start 2025, it increased that payout to $1.10 per share across the whole year. 2025 would count as one year toward the 25-year streak.
However, technically speaking, dividend increases are calculated across the entire year. So what really mattered wasn’t the increase from $1 to $1.10 per share, but the fact that Woodley Inc. paid out $4 per share across 2024, then $4.40 per share across 2025. Why does that matter? Well …
Example: Woodley Inc. started 2024 paying 90¢ per share per quarter. In mid-2024, it raised its quarterly payout to $1 per share. It paid $3.80 per share (90¢ + 90¢ + $1 + $1) across all of 2024. The next year, Woodley Inc. didn’t increase its quarterly dividend, so it paid out $1 per share quarterly, and thus $4 per share ($1 + $1 + $1 + $1) across the whole year. 2025 would still count as one year toward the 25-year streak. (However, the company would have to increase the quarterly dividend in 2026 to earn another year of growth.)
In short: A Dividend Aristocrat doesn’t necessarily have to raise its periodic dividend every year to achieve a streak of annual dividend growth. (But they frequently do.)
Lastly, whenever a Dividend Aristocrat announces a dividend increase, we in the media typically give them the benefit of the doubt and add another year to their dividend-growth streak. But on rare occasions, the year doesn’t end up qualifying, usually resulting in a broken streak and exclusion from the Aristocrats.
Example: Woodley Inc. paid $1 per share quarterly in 2024, good for $4 per share across the entire year. In January 2025, the company increased the quarterly dividend to $1.10 per share. In mid-year, sudden cash-flow issues forced the company to reduce its dividend by 50%, to 55¢ per share. Woodley Inc. paid out $3.30 per share ($1.10 + $1.10 + 55¢ + 55¢) across 2025. That would not count as a year of dividend growth, thus Woodley Inc.’s dividend-growth streak would end.
Related: 17 Best Investment Apps and Platforms [Free + Paid]
The Best-Rated Dividend Aristocrats Right Now
Currently, there are 69 S&P 500 Dividend Aristocrats—a group of stocks that most people would generally consider to be stable, dependable companies.
But that doesn’t mean they all make equally worthy investments.
Let’s separate the wheat from the chaff. I’ll show you the 10 best-rated Dividend Aristocrats right now, as determined by their consensus analyst rating, provided by S&P Global Market Intelligence. S&P boils down consensus ratings down to a numerical system where …
— 1 to 1.5: Strong Buy
— 1.5 to 2.5: Buy
— 2.5 to 3.5: Hold
— 3.5 to 4.5: Sell
— 4.5 to 5: Strong Sell
All of the Dividend Aristocrats on this list have a rating of 2 or less, indicating that at worst they enjoy a pretty firm consensus Buy rating, if not an outright Strong Buy rating.
Stocks are listed in reverse order of consensus analyst rating (from worst to best).
Do you want to get serious about saving and planning for retirement? Sign up for Retire With Riley, Young and the Invested’s free retirement planning newsletter.
Best Dividend Aristocrat #10: Emerson Electric
DepositPhotos
— Sector: Industrials
— Market cap: $72.0 billion
— Dividend yield: 1.7%
— Consensus analyst rating: 1.82 (Buy)
Emerson Electric (EMR) is an industrial-sector firm that was founded in 1890 and headquartered in St. Louis. Emerson has established itself as a global leader in technology and engineering, providing innovative solutions in process control, industrial automation, heating, ventilation, and air conditioning (HVAC), and more.
The company’s emphasis on technological advancement and diversified market penetration has been crucial in maintaining a competitive edge over the last 125-plus years. What once was a maker of electric motors and fans is now a global industrial-technology giant that produces not just tens of thousands of products, but even industry, automation, and operations management software.
Related: The 7 Best Gold ETFs You Can Buy
It’s also a popular company among Wall Street’s analyst set, enjoying 19 Buy calls versus just six Holds and two Sells.
“While tariff uncertainty is putting a lid on capital spending in the near term, we see strengthening traction for automation demand as U.S. reshoring matures and manufacturers seek to hedge against labor cost inflation and labor shortages,” says CFRA analyst Jonathan Sakraida (Buy). “We anticipate additional earnings with accretive M&A activity looking to 2026 as EMR makes progress on deleveraging its balance sheet over the next 12 months. EMR’s margin quality will likely continue to improve as the company’s portfolio pivots further toward software offerings, providing upside to earnings growth.”
While its most recent payout increases haven’t been much to crow about, Emerson Electric has delivered decades of consistent dividend growth. This industrial firm’s dividend track record spans 69 consecutive year. The most recent upgrade came in November 2025, when the company announced a 5% improvement, to 52.75¢ per share quarterly.
Related: How to Get Free Stocks for Signing Up: 10 Apps w/Free Shares
Best Dividend Aristocrat #9: Abbott Laboratories
— Sector: Health care
— Market cap: $219.4 billion
— Dividend yield: 1.8%
— Consensus analyst rating: 1.76 (Buy)
Abbott Laboratories (ABT) is a large health care firm that develops, makes, and sells medical devices, diagnostic products, nutritional products, and generic pharmaceuticals. Among other things, it’s responsible for FreeStyle (and FreeStyle Libre) glucose monitors, Pedialyte hydration products, Similac formulas, PediaSure children’s nutritional products, and BinaxNow COVID-19 antigen tests.
Medical devices are Abbott’s biggest breadwinner at nearly half of revenues, and they’ve been a key driver of growth of late. The company has reported 11 consecutive quarters of double-digit top-line growth in medical devices; in Q3, it enjoyed a 19% pop in diabetes care revenues and a 14% jump in structural heart product sales.
Abbott is coming up against at least short-term headwinds related to its diagnostics business, with the company recently downgrading its full-year revenue estimates. Regardless, ABT enjoys a crowded bull camp of 21 Buys (versus eight Holds and no sells).
Related: 8 Best-in-Class Bond Funds to Buy
“Abbott’s continued growth on the MedTech side, disciplined M&A, and margin leverage over time buoy our constructive stance on the name,” say Oppenheimer analysts, who rate the stock at Outperform [equivalent of Buy]. “The relative buffers provided by the different business segments, the $7 billion cash-on-hand, ~2% dividend yield, disciplined M&A approach, and ‘potential’ for margin expansion form the basis of our constructive stance on the name.”
“We believe Abbott’s growth drivers (including the FreeStyle Libre, electrophysiology products, leadless pacemakers, and cardiovascular devices) as well as its ability to develop and launch new products could lead to continued growth in sales and earnings,” adds Argus Research analyst David Toung (Buy). “We note that Abbott plans to expand the FreeStyle portfolio beyond the diabetic market to the consumer market.”
Abbott isn’t just a Dividend Aristocrat—it’s a Dividend King, which means it has upgraded its payout for at least 50 consecutive years (53, to be specific). The most recent increase to the quarterly payout—a 7% hike to 59¢ per share—was announced in December 2024. The dividend itself dates back a full century, to 1924.
Related: 15 Best Investing Research & Stock Analysis Websites
Best Dividend Aristocrat #8: Cardinal Health
— Sector: Health care
— Market cap: $49.3 billion
— Dividend yield: 1.0%
— Consensus analyst rating: 1.75 (Buy)
Cardinal Health (CAH) is a relatively boring but extremely essential cog in the health care machine, providing both products and services to hospitals, health care systems, pharmacies, ambulatory surgery centers, physician offices, even home patients.
Just a small sample of its offerings include distributing branded, generic, and specialty pharmaceutical, medical supplies, over-the-counter health care products, and consumer products; pharmacy management services; Cardinal Health-manufactured and branded medical, surgical, and laboratory products; and supply chain services. This wide reach provides both revenue diversification across the sector, as well as ample opportunity for growth in several segments.
Related: 10 Best ETFs to Beat Back a Bear Market
Cardinal shares have rocketed higher in 2025, up 75% as of this writing, with the latest spurt coming on the back of stellar fiscal first-quarter earnings reported at the end of October.
“CAH delivered a strong [Q1], raising guidance and, most importantly, delivering strong core pharma numbers against a low buy-side bar,” says Jefferies analyst Brian Tanquilut, who rates the stock at Buy. “Despite the raise, [fiscal 2026] guidance still looks conservative to us, given the strong Q1 performance even after accounting for modest accretion from the now closed Solaris acquisition.”
The consensus is for more of the same; Tanquilut is one of 11 Buys on the stock, in contrast to four Holds and one Sell.
Cardinal Health also extended its dividend growth streak earlier this year, in May 2025, when it raised its payout by 1% to 51.07¢ per share. That puts the Dividend Aristocrat at 29 years of uninterrupted payout increases.
Best Dividend Aristocrat #7: Amcor
— Sector: Consumer discretionary
— Market cap: $19.4 billion
— Dividend yield: 6.1%
— Consensus analyst rating: 1.75 (Buy)
The most recent round of analyst data has pushed Roper Technologies out, and global packaging giant Amcor (AMCR) back in.
Amcor produces flexible and rigid packaging products for a wide variety of industries. Its rigid packaging is used on any number of grocery-store items, including soft drinks, water, sports drinks, sauces, spreads, even personal-care items, while its flexible packaging is used in the food-and-beverage, medical, and pharmaceutical industries, among others. (Thus, while Amcor is considered a consumer discretionary name, it’s truly closer to being a consumer-industrial hybrid.)
Amcor is also a lot bigger than it was this time last year, having completed its acquisition of Berry Global in April 2025. The combined company now boasts more than 400 facilities and 75,000 employees, with a reach of over 40 countries.
Related: 7 Low- and Minimum-Volatility ETFs for Peace of Mind
Mergers and acquisitions (M&A) can cause short-term turbulence, and that very well could be the case at Amcor, where analysts are largely bullish (nine Buys versus three Holds and no Sells) but cautious about the months ahead.
“We believe the company has multiple avenues at its disposal to drive more pronounced volume growth, EBITDA, and FCF [following the Berry] acquisition, which we view as a transformational transaction,” says Truist Managing Director Michael Roxland, who rates shares at Buy. “Volumes should improve by at least 100bps through a combination of cross-selling, new geographies, and do-it-yourself. Further, EBITDA and FCF growth will be driven by better volumes as well as cost synergies, which we believe have upside.”
This Dividend Aristocrat currently has more than four decades of uninterrupted dividend growth. It marked 42 years with the announcement of a 2% raise, to 13¢ per share, in November 2025.
Make Young and the Invested your preferred news source on Google
Simply go to your preferences page and select the ✓ box for Young and the Invested. Once you’ve made this update, you’ll see Young and the Invested show up more often in Google’s “Top Stories” feed, as well as in a dedicated “From Your Sources” section on Google’s search results page.
Related: 9 Best Fidelity ETFs for 2025 [Invest Tactically]
Best Dividend Aristocrat #6: Coca-Cola
— Sector: Consumer staples
— Market cap: $305.9 billion
— Dividend yield: 2.9%
— Consensus analyst rating: 1.58 (Buy)
The Dividend Aristocrats are littered with consumer staples stocks: companies that make goods considered to be basic necessities.
It’s pretty easy to understand why. When times get tough, households might spend less on vacations and designer jeans, but they’re not going to stop going to the grocery store. (This is why staples make for some of the best dividend stocks for beginners, too.)
Take Atlanta-based beverage titan Coca-Cola (KO), which has more than 130 years of operating history and currently serves up more than 200 brands to more than 200 countries and territories.
Related: Best Vanguard Funds to Hold in an HSA
Sugary soft drinks might not be a growth business in an age of healthier living, but Coca-Cola products still enjoy strong baseline demand. But more importantly: This mega-cap powerhouse is more than just Coke. Coca-Cola boasts a wide variety of other beverage brands, including Vitaminwater and Dasani water, Fuze teas, Powerade sports drinks, Minute Maid juices, Costa Coffee, Fairlife ultra-filtered milk, and many more drinks that are likely to meet your definition of a household staple.
But Coke isn’t just a consumer staples stock—it’s one of the best, boasting a huge bull contingent of 21 Buys versus three Holds and not a single Sell call right now.
“Coke remains our top pick, with strong and durable pricing power, existing historical volume growth, sustained market share gains, as well as increasing contribution from the high-growth Fairlife brand,” says Morgan Stanley analyst Dara Mohsenian. BNP Paribas Exane senior research analyst Kevin Grundy (Outperform) also cites the “under-appreciated Fairlife contribution” in his bull thesis, as well as a “best-in-class portfolio, market share, return of capital, free cash flow story … [and] attractive valuation.”
And then there’s Coca-Cola’s place among the Dividend Aristocrats (and Kings). KO currently boasts 63 years of unfettered dividend growth, most recently announcing a 5% hike to its payout (to 51¢ per share) in February 2025.
Related: 7 Best Value Stocks for 2025 [Smart Picks to Buy]
Best Dividend Aristocrat #5: Linde
— Sector: Materials
— Market cap: $192.9 billion
— Dividend yield: 1.4%
— Consensus analyst rating: 1.52 (Buy)
Materials companies are often extremely cyclical investments that tend to rise and fall based on broad-based economic trends and industrial demand. That said, a few have passed the test of time and managed to deliver consistent dividends regardless.
Case in point: Ireland-based Linde plc (LIN). Linde is the world’s largest industrial gas producer, offering oxygen, nitrogen, argon, helium, hydrogen, electronic gases, acetylene, and rare gases. It also produces air separation, synthesis, olefin, and other plants for third-party customers. And it does this across every continent.
While this is certainly a cyclical business, Linde offers some shelter from the economic shocks that many of its businessmates suffer. That’s in part because of its diverse offerings, but also because of the industries it supplies.
Related: The Best REITs to Invest In
“The company has a strong presence in many defensive end markets, including health care, food and beverages, and electronics that should generate consistent revenues even in a soft economic environment,” says Argus Research analyst Alexandra Yates, who is one of 22 Buys on LIN shares (vs. two Holds and one Sell). “In addition, Linde currently manages a significant $10 billion backlog of projects, mostly under contract with blue-chip companies, which provide strong and steady cash flow and maintain a solid balance sheet. The long-term contracts allow for safe and consistent returns and position the company for future growth.”
In fact, its business has been so relatively stable that it has—by virtue of its 2018 merger with fellow gas giant Praxair—been able to deliver 32 consecutive years of increased dividends to its shareholders, most recently an 8% hike announced in February 2025, to $1.50 per share.
While long-term buy-and-holders might look away from the materials sector, Linde sticks out as both a Dividend Aristocrat and a surprisingly stable “forever stock.”
Do you want to get serious about saving and planning for retirement? Sign up for Retire With Riley, Young and the Invested’s free retirement planning newsletter.
Best Dividend Aristocrat #4: West Pharmaceutical
— Sector: Health care
— Market cap: $18.6 billion
— Dividend yield: 0.3%
— Consensus analyst rating: 1.40 (Strong Buy)
When is a pharmaceutical company not a pharmaceutical company? When it’s West Pharmaceutical (WST).
Apologies to those of you who hate riddles.
Anyways, West Pharmaceutical designs, manufactures, and sells not drugs, but the containment and delivery systems that house those drugs. Its products include syringe and cartridge components, stoppers and seals for injectable packaging systems, entire self-injection systems, and drug containment solutions (including a cyclic olefin polymer called Crystal Zenith). It also provides analytical lab services, regulatory expertise, and other integrated solutions.
Related: 7 Best T. Rowe Price Funds to Buy and Hold
In short: Whereas buying a pharmaceutical company is a play on the success of that pharmaceutical company’s treatments, buying West Pharmaceutical is effectively a play on the overall growth of the pharmaceutical industry … and, of course, West’s ability to convince other pharmaceutical companies that it’s the ideal packaging partner.
Wall Street is certainly convinced—the stock enjoys 13 Buys versus two Holds and no Sells.
“We rate the stock Outperform, and that rating is predicated on West being a high-quality, franchise name that provides quality and dependable earnings and cash flow, a clear leadership competitive position, and access to attractive end-market trends without single-product or technology risk,” say William Blair analysts Matt Larew and Jacob Krahenbuhl.
A business built on the broader growth of the health care sector has also meant growing income over time, which WST has been happy to increasingly share with investors. In late July 2025, the company announced its 33rd consecutive hike to the cash distribution—a 22¢-per-share payout set to begin in November.
Related: 7 Best Vanguard Retirement Funds
Best Dividend Aristocrat #3: Nucor
— Sector: Materials
— Market cap: $34.0 billion
— Dividend yield: 1.5%
— Consensus analyst rating: 1.36 (Strong Buy)
Nucor (NUE) is North America’s largest steel manufacturer and recycler. It produces a wide variety of products, including hot-rolled, cold-rolled, and galvanized sheet steel products; bar steel products; and steel joists and joist girders, among other products. It also has a raw materials segment that produces direct reduced iron, processes scrap metal, and even engages in natural gas production.
It’s among the top-rated materials stocks right now, too, enjoying 13 Buys versus just one Hold and no Sells.
Related: How to Pass an IRA to Heirs [Without Leaving a Tax Mess]
“Backlogs remain healthy and Nucor, in our view, is well-positioned to capture further market share. Organic growth pipeline is progressing, with multiple projects at or nearing completion,” says BMO Capital Markets metals and mining analyst Katja Jancic, who rates shares at Outperform. “Our view remains that these investments will over time support higher through-cycle profitability and FCF, which in combination with a healthy balance sheet should offer increasing shareholder return potential.”
It’s a reminder that Nucor is another highly cyclical stock whose fates are closely tethered to economic activity, both here and abroad.
That’s not exactly fertile breeding ground for dividend stability, but Nucor has delivered enough of it—52 years—to qualify as a Dividend King. No. 52 came in December 2024, when the company raised its payout by 3.7%, to 55¢ per share.
Related: Direct Indexing: A (Tax-)Smarter Way to Index Your Investments
Best Dividend Aristocrat #2: Walmart
— Sector: Consumer staples
— Market cap: $802.2 billion
— Dividend yield: 0.9%
— Consensus analyst rating: 1.35 (Strong Buy)
Walmart (WMT) needs no introduction, but I’ll give it one anyways.
Walmart is a global retailing behemoth, operating nearly 11,000 stores and clubs in 19 countries, including 4,600 stores—not just Supercenters, but also discount stores, Neighborhood Markets and small-format stores—in the U.S. That doesn’t even include its 600 Sam’s Club warehouse-club locations.
WMT is frequently contrasted with fellow big-box store Target—the former is considered a lower-priced but lower-quality retailer, while the latter is pricier but perceived to be more upscale. Fortunately for Walmart, at least part of that equation is changing.
Related: 8 Best Stock Portfolio Tracking Apps [Stock Portfolio Trackers]
“‘I don’t like shopping at Walmart’; well, there are solutions for that too,” says Truist managing director Scot Ciccarelli, one of 41 Buys on the stock (versus one Hold and one Sell). “Many ‘suburban soccer moms’ would often prefer Target to Walmart, given Target’s real estate strategy and focus on solid value in discretionary goods like apparel and home goods. However, we think these historical biases are fading, given the improvements to Walmart’s store standards, widening price gaps and, maybe most importantly, convenience and e-commerce options that simply didn’t exist years ago.”
Among the things helping to drive both Walmart’s reputation and growth is its fresh-food offerings.
“The fresh category at WMT has experienced 70% growth over the past 9-10 years, noting it is up 50% since 2020,” says Goldman Sachs analyst Kate McShane (Buy). “Per management, fresh is important for the perception of the overall quality of the store, and in-stocks are restocked every day. … WMT is working to continue to elevate its assortment within the grocery category, noting that an elevated fresh selection can be rolled out in a store without a full remodel.”
Walmart is also a king among Dividend Aristocrats. Its 52nd consecutive dividend improvement came in March 2025, when it juiced its distribution by 13%, to 23.5¢ per share.
Best Dividend Aristocrat #1: S&P Global
— Sector: Financials
— Market cap: $148.6 billion
— Dividend yield: 0.8%
— Consensus analyst rating: 1.35 (Strong Buy)
I get a little enjoyment out of noting that S&P Global (SPGI)—parent of S&P Dow Jones Indices, which produces the S&P 500—is also the best-ranked Dividend Aristocrat within the S&P 500.
The S&P 500, of course, is America’s most ubiquitous index—literally trillions of dollars worth of fund assets are either indexed to it or benchmarked against it. (And as I point out every year in my list of the best ETFs, active managers have a really hard time beating it.)
Related: How to Choose a Financial Advisor
But S&P Global is more than just the S&P 500. It’s also responsible for the Dow Jones Industrial Average, the Dow Jones Transportation Index (the oldest index in use), and more than a million other indexes across a number of asset classes. It’s also home to …
— S&P Global Ratings: Credit ratings, research, and analytics
— S&P Global Commodity Insights: Information and benchmark prices for commodities and energy
— S&P Global Market Intelligence: A wide variety of financial markets and asset data and analytics, enterprise technology, and advisory services.
— S&P Global Mobility: Solutions for vehicle manufacturers, automotive suppliers, mobility service providers, and other companies in the automotive value chain. (Note: The company announced this year that Mobility will be spun off, likely sometime in 2026.)
“We are Buy rated on S&P Global (SPGI), seeing the company as a bellwether for the info services sector and a category leader for financial analytics and essential services,” says Citi analyst Peter Christiansen, who is one of 22 analysts with Buy-equivalent calls on SPGI, versus one Hold and no Sells. “We think investors can appreciate the company’s diversification across various asset classes and high degree of subscription/recurring revenue, which positions the company well in both positive and challenging market environments. … We also believe S&P Global’s AI initiatives present value-added features that can enhance user engagement and potentially, improved pricing power.”
This varied and growing set of businesses has allowed S&P Global to pay dividends every year since 1937, as well as grow those dividends for 52 consecutive years. SPGI’s latest improvement was a 5.5% bump, to 96¢ per share, announced in January 2025.
Want to talk more about your financial goals or concerns? Our services include comprehensive financial planning, investment management, estate planning, taxes, and more! Schedule a call with Riley to discuss what you need, and what we can do for you.
Related: 5 Best Vanguard Dividend Funds for 2025 [Low-Cost Income]
What’s better than a smart, sound dividend income strategy? How about a smart, sound dividend income strategy with very little money coming out of your pocket?
If that sounds good to you, you need look no farther than low-cost pioneer Vanguard, which offers up a number of payout-oriented products. Find out what you need to know in our list of five top-notch Vanguard dividend funds.
The 7 Best Dividend ETFs [Get Income + Diversify]
We love exchange-traded funds (ETFs) because they can provide one-click access to hundreds, even thousands of stocks, while charging often minuscule fees.
One way to put that low-cost diversification to work? Collecting dividends. But trying to choose from literally hundreds of income-producing funds could take up a lot more time than you have. So let us help you narrow the field—check out our list of seven top dividend ETFs.
Please Don’t Forget to Like, Follow and Comment
Did you find this article helpful? We’d love to hear your thoughts! Leave a comment with the box on the left-hand side of the screen and share your thoughts.
Also, do you want to stay up-to-date on our latest content?
1. Follow us by clicking the [+ Follow] button above,
2. Subscribe to Retire With Riley, our free weekly retirement planning newsletter, and
3. Give the article a Thumbs Up on the top-left side of the screen.
4. And lastly, if you think this information would benefit your friends and family, don’t hesitate to share it with them!
